GSK Antes Up $3 Billion to Settle Health Care Fraud Case
In a victory for consumers, British pharma giant GlaxoSmithKline (GSK) will pay $3 billion in fines and plead guilty to criminal charges that it unlawfully promoted its antidepressant medicines Paxil and Wellbutrin